Question 1

Am I eligible for this trial based on my current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of hydroxychloroquine and chloroquine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for COVID-19?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the process look like if I decide to participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience any side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds clinical trial (NCT04346667). Contact the study team or your healthcare provider for specific answers.

What this study is about